Axonics Modulation Technologies, Inc. (AXNX): Price and Financial Metrics

Axonics Modulation Technologies, Inc. (AXNX): $67.22

0.11 (-0.16%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

AXNX Price/Volume Stats

Current price $67.22 52-week high $69.68
Prev. close $67.33 52-week low $47.59
Day low $67.12 Volume 291,100
Day high $67.50 Avg. volume 1,078,605
50-day MA $67.67 Dividend yield N/A
200-day MA $62.10 Market Cap 3.43B

AXNX Stock Price Chart Interactive Chart >


Axonics Modulation Technologies, Inc. (AXNX) Company Bio


Axonics Modulation Technologies, Inc. is a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation (SNM) solutions. The company focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in 2013 and is headquartered in Irvine, CA.


AXNX Latest News Stream


Event/Time News Detail
Loading, please wait...

AXNX Latest Social Stream


Loading social stream, please wait...

View Full AXNX Social Stream

Latest AXNX News From Around the Web

Below are the latest news stories about AXONICS INC that investors may wish to consider to help them evaluate AXNX as an investment opportunity.

Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript

Axonics, Inc. (AXNX)

Q1 2023 Earnings Conference Call

May 1, 2023 4:30 PM ET

Company Participants

Neil Bhalodkar - VP of IR

Raymond Cohen - CEO

Dan Dearen - President and CFO

Conference Call Participants

Chris Pasquale - Nephron Research

Richard Newitter - Truist Securities

Nathan Treyback - Wells Fargo

Adam Maeder - Piper Sandler

Michael Polark - Wolfe Research

Shagun Singh - RBC Capital Markets

Mike Matson - Needham and Company

Anthony Petrone - Mizuho Securities

Michael Sarcone - Jefferies

Presentation

Operator

Thank you for standing by and welcome to the Axonics' First Quarter 2023 Results Conferen...

SA Transcripts on Seeking Alpha | May 2, 2023

Axonics Modulation Technologies GAAP EPS of -$0.19, revenue of $70.7M

  • Axonics Modulation Technologies press release (NASDAQ:AXNX): Q1 GAAP EPS of -$0.19.
  • Revenue of $70.7M (+46.0% Y/Y).
  • Gross margin was 74.3% in 1Q23 compared to 68.7% in the prior year period.
  • Operating expenses were $66.9 million in 1Q23 and included a $1.8 million
  • Adjusted EBITDA was $0.9 million in 1Q23 compared to an adjusted EBITDA loss of $13.4 million in the prior year period.
  • Net loss was $9...

    Seeking Alpha | May 1, 2023

Read More 'AXNX' Stories Here

AXNX Price Returns

1-mo 0.79%
3-mo -2.05%
6-mo 18.57%
1-year 38.48%
3-year 16.22%
5-year 100.06%
YTD 8.02%
2023 -0.48%
2022 11.66%
2021 12.18%
2020 80.15%
2019 83.39%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!